Verisante Technology Inc (VRSEF) 0.1456 $VRSEF
Verisante Technology, Inc. Recognizes May as National Skin Cancer Awareness Month
Marketwire - Fri May 02, 8:02AM CDT
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: VRSEF) (the "Company" or "Verisante"
, a leader in cancer detection technology, recognizes May as skin cancer awareness month and reminds the public to wear sunscreen and get screened for skin cancer.
Verisante Technology, Inc. Announces 2013 Year End Results and Strategy for Direct Distribution
Marketwire - Wed Apr 30, 7:57PM CDT
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: VRSEF) (the "Company" or "Verisante", a leader in cancer detection technology, announced today that the Company has released its financial results for the year ended December 31, 2013.
Verisante Technology's CEO Thomas Braun Interviewed by The Life Sciences Report
Marketwire - Mon Apr 21, 8:15AM CDT
Early detection of cancer has a profound impact on the effectiveness of medical/surgical treatments, as well as on the long-term prognoses of patients. Consequently, new technologies are evolving with the ability to detect cancers in their earliest and most treatable stages. In this interview with The Life Sciences Report, Thomas Braun, president and CEO of Verisante Technology Inc. (TSX VENTURE: VRS) (OTCQX: VRSEF), describes his company's Aura and Core devices, and their utility in early cancer detection.
BTV-Business Television -- Verisante Technology, Cancer Detection Technology, Announces Chinese Patent
Newsfile Corp - Fri Apr 04, 1:01PM CDT
full story)
Verisante Technology's Early Cancer Detection Devices, CEO Clip Video
Newsfile Corp - Thu Mar 20, 10:01AM CDT
full story)
Verisante Completes Private Placement
Marketwire - Tue Mar 18, 12:04PM CDT
Verisante Technology, Inc. (TSX VENTURE: VRS) (OTCQX: VRSEF) (the "Company" or "Verisante", announced today that it has closed a non-brokered private placement of 2,827,000 units ("Units" at a price of $0.17 per Unit for gross proceeds of $480,590. Each Unit consists of one common share of the Company and one common share purchase warrant (a "Warrant". Each Warrant entitles the holder to acquire a common share at a price of $0.25 for a period of 24 months from the date of issuance, subject to certain acceleration provisions contained within the warrant certificate.
Verisante Technology, Inc. Expands Intellectual Property Portfolio
Marketwire - Wed Mar 12, 9:01AM CDT
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: VRSEF) (the "Company" or "Verisante", a leader in cancer detection technology, announced today that the Chinese Patent Office has issued a decision to grant Patent Application No. 2006800074 entitled "Methods and Apparatus for Measuring Cancerous Changes from Reflectance Spectral Measurements Obtained During Endoscopy Imaging".
Verisante Technology, Inc. Grows Sales and Marketing Team
Marketwire - Wed Feb 26, 9:02AM CST
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: VRSEF) (the "Company" or "Verisante", a leader in cancer detection technology, announced today that the Company has hired Jason Mangler as Director of Sales to guide the Company's world-wide sales and marketing strategy. Verisante has also hired Kim Ellis, as the Company's Sales Representative for Western Canada.
Launch: Ericsson brings capacity with 'Small Cell as a Service'
M2 - Thu Feb 13, 7:16AM CST
- Enables increased network capacity in environments where large numbers of people gather and consume large amounts of data
Verisante Technology, Inc. Launches New Product at SPIE Photonics West 2014 in San Francisco, CA
Marketwire - Tue Feb 04, 8:31AM CST
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: VRSEF) (the "Company" or "Verisante", a leader in cancer detection technology, announced today that the Company is launching a new product at the SPIE Photonics West 2014 industry exhibit in San Francisco, California from February 4-6, 2014. Photonics West is the annual flagship event for the optics and photonics industry, with 20,000 attendees expected to attend.
A.M. Best Affirms Ratings of LocalTapiola General Mutual Insurance Company
A.M. Best Company - AMBest - Fri Jan 17, 10:41AM CST
A.M. Best Europe â?? Rating Services Limited has affirmed the financial strength rating of A (Excellent) and issuer credit rating of â??aâ? of LocalTapiola General Mutual Insurance Company (LocalTapiola) (Finland). The outlook for both ratings remains stable.
Verisante Technology, Inc. Announces 2013 Third Quarter Results and Plans for Direct Distribution in Canada
Marketwire - Thu Nov 28, 12:58PM CST
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: RSEF) (the "Company" or "Verisante", a leader in cancer detection technology, announced today that the Company has released its financial results for the third quarter ended September 30, 2013.
BTV-Business Television - Verisante Technology Innovation for the Early Detection of Skin Cancer
Newsfile Corp - Fri Nov 08, 6:34PM CST
full story)
Verisante Technology, Inc. Recognizes May as National Skin Cancer Awareness Month
Marketwire - Fri May 02, 8:02AM CDT
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: VRSEF) (the "Company" or "Verisante"
, a leader in cancer detection technology, recognizes May as skin cancer awareness month and reminds the public to wear sunscreen and get screened for skin cancer. Verisante Technology, Inc. Announces 2013 Year End Results and Strategy for Direct Distribution
Marketwire - Wed Apr 30, 7:57PM CDT
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: VRSEF) (the "Company" or "Verisante"
, a leader in cancer detection technology, announced today that the Company has released its financial results for the year ended December 31, 2013. Verisante Technology's CEO Thomas Braun Interviewed by The Life Sciences Report
Marketwire - Mon Apr 21, 8:15AM CDT
Early detection of cancer has a profound impact on the effectiveness of medical/surgical treatments, as well as on the long-term prognoses of patients. Consequently, new technologies are evolving with the ability to detect cancers in their earliest and most treatable stages. In this interview with The Life Sciences Report, Thomas Braun, president and CEO of Verisante Technology Inc. (TSX VENTURE: VRS) (OTCQX: VRSEF), describes his company's Aura and Core devices, and their utility in early cancer detection.
BTV-Business Television -- Verisante Technology, Cancer Detection Technology, Announces Chinese Patent
Newsfile Corp - Fri Apr 04, 1:01PM CDT
full story)
Verisante Technology's Early Cancer Detection Devices, CEO Clip Video
Newsfile Corp - Thu Mar 20, 10:01AM CDT
full story)
Verisante Completes Private Placement
Marketwire - Tue Mar 18, 12:04PM CDT
Verisante Technology, Inc. (TSX VENTURE: VRS) (OTCQX: VRSEF) (the "Company" or "Verisante"
, announced today that it has closed a non-brokered private placement of 2,827,000 units ("Units" at a price of $0.17 per Unit for gross proceeds of $480,590. Each Unit consists of one common share of the Company and one common share purchase warrant (a "Warrant". Each Warrant entitles the holder to acquire a common share at a price of $0.25 for a period of 24 months from the date of issuance, subject to certain acceleration provisions contained within the warrant certificate. Verisante Technology, Inc. Expands Intellectual Property Portfolio
Marketwire - Wed Mar 12, 9:01AM CDT
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: VRSEF) (the "Company" or "Verisante"
, a leader in cancer detection technology, announced today that the Chinese Patent Office has issued a decision to grant Patent Application No. 2006800074 entitled "Methods and Apparatus for Measuring Cancerous Changes from Reflectance Spectral Measurements Obtained During Endoscopy Imaging". Verisante Technology, Inc. Grows Sales and Marketing Team
Marketwire - Wed Feb 26, 9:02AM CST
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: VRSEF) (the "Company" or "Verisante"
, a leader in cancer detection technology, announced today that the Company has hired Jason Mangler as Director of Sales to guide the Company's world-wide sales and marketing strategy. Verisante has also hired Kim Ellis, as the Company's Sales Representative for Western Canada. Launch: Ericsson brings capacity with 'Small Cell as a Service'
M2 - Thu Feb 13, 7:16AM CST
- Enables increased network capacity in environments where large numbers of people gather and consume large amounts of data
Verisante Technology, Inc. Launches New Product at SPIE Photonics West 2014 in San Francisco, CA
Marketwire - Tue Feb 04, 8:31AM CST
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: VRSEF) (the "Company" or "Verisante"
, a leader in cancer detection technology, announced today that the Company is launching a new product at the SPIE Photonics West 2014 industry exhibit in San Francisco, California from February 4-6, 2014. Photonics West is the annual flagship event for the optics and photonics industry, with 20,000 attendees expected to attend. A.M. Best Affirms Ratings of LocalTapiola General Mutual Insurance Company
A.M. Best Company - AMBest - Fri Jan 17, 10:41AM CST
A.M. Best Europe â?? Rating Services Limited has affirmed the financial strength rating of A (Excellent) and issuer credit rating of â??aâ? of LocalTapiola General Mutual Insurance Company (LocalTapiola) (Finland). The outlook for both ratings remains stable.
Verisante Technology, Inc. Announces 2013 Third Quarter Results and Plans for Direct Distribution in Canada
Marketwire - Thu Nov 28, 12:58PM CST
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: RSEF) (the "Company" or "Verisante"
, a leader in cancer detection technology, announced today that the Company has released its financial results for the third quarter ended September 30, 2013. BTV-Business Television - Verisante Technology Innovation for the Early Detection of Skin Cancer
Newsfile Corp - Fri Nov 08, 6:34PM CST
full story)
